Tag:
NIH
Latest Headlines
Latest Headlines
House passes 21st Century Cures bill
Members of U.S. House of Representatives voted 344 to 77 today to approve the 21st Century Cures bill. It now goes to the Senate for consideration. The bill provides more funds for the FDA and NIH, but detractors are concerned about provisions that change the way drugs and devices are developed and approved.
UPDATED: 21st Century Cures drug bill triggers a DC dust-up over relaxed development regs
Lawmakers in the House are expected to step up and cast their votes on the 21st Century Cures Act today, a big step toward once again shaking up the legal framework built to guide drug development in the U.S. while significantly boosting the amount of funding that flows to the NIH.
NIAID launches PhI trial of investigational West Nile virus vaccine
The mosquito-borne West Nile virus has infected more than 41,000 people and killed more than 1,700 people in the U.S. since 1999. But while there is an effective veterinary vaccine for the virus, there is no commercially available human vaccine. The National Institutes of Health's NIAID is launching a Phase I trial of a human vaccine at Duke University.
NIH provides Great Basin Scientific and BYU $5M+ to develop rapid test for CRE
The National Institutes of Health has awarded more than $5 million over 5 years to diagnostics company Great Basin Scientific and Brigham Young University to develop a rapid molecular diagnostic test from whole blood for carbapenem-resistant Enterobacteriaceae (CRE).
NIH provides Great Basin Scientific and BYU $5M+ to develop rapid test for CRE
The National Institutes of Health has awarded more than $5 million over 5 years to diagnostics company Great Basin Scientific and Brigham Young University to develop a rapid molecular diagnostic test from whole blood for carbapenem-resistant Enterobacteriaceae (CRE).
NIH grants Northeastern prof $1.4M to address 'bottleneck' in vaccine development
The National Institutes of Health has awarded Northeastern professor of chemical engineering Shashi Murthy a four-year $1.4 million grant to develop a novel instrument that would ease a "tremendous bottleneck" in vaccine development.
Sanofi-Aventis to see slew of Plavix generics join Japan NHI reimbursement list
Japan's National Health Insurance (NHI) has confirmed that a slew of generic versions of Sanofi's Plavix will join the reimbursement list after the latest review, a move tipped by the company in its first-quarter earnings call as well.
NIH finds sand fly saliva may be the key to leishmaniasis vaccine
Researchers at the National Institutes of Health reported that a leishmaniasis vaccine based on sand fly saliva has worked well in monkeys.
Shire's Vyvanse could bag another lucrative new market in menopausal women
Shire has been working hard to expand blockbuster Vyvanse beyond ADHD. And now, new research has suggested another avenue for doing just that.
Serious manufacturing issues tied to fungal contamination in NIH facility
The FDA, which has been going full bore after offending compounding pharmacies, has now turned its attention to one of its sister agencies. The result is that the National Institutes of Health has closed its Pharmaceutical Development Section after FDA inspectors found "serious manufacturing problems" that resulted in fungal contamination in a drug used in clinical trials.
- « first
- ‹ previous
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- next ›
- last »
